Fertility and Sterility/LinkedIn
Mar 15, 2026, 14:59
Tamoxifen or Letrozole for Fertility Preservation in Breast Cancer! – Fertility and Sterility
Fertility and Sterility shared a post on LinkedIn:
“In F and S Reports:
Reproductive outcomes after fertility preservation using tamoxifen or letrozole in women with breast cancer: A long-term follow-up
Title: Reproductive outcomes after fertility preservation using tamoxifen or letrozole in women with breast cancer: a long-term follow-up
Authors: Bo F. Paans, Madelon van Wely, Catharina C.M. Beerendonk, Jan Peter de Bruin, Astrid E.P. Cantineau, Taghride Dahhan, Nicole F. Klijn, Leonie A. Louwe, Jesper M.J. Smeenk, Mariëtte Goddijn, Eva M.E. Balkenende
Stay updated on all scientific advances in the field of fertility with Fertility News.
Astrid E.P. Cantineau
Bo F. Paans
Breast Cancer
Catharina C.M. Beerendonk
Eva M.E. Balkenende
Fertility
Fertility and Sterility
Fertility News
fertility preservation
Jan Peter de Bruin
Jesper M.J. Smeenk
Leonie A. Louwe
Letrozole
Madelon van Wely
Mariette Goddijn
Nicole F. Klijn
reproductive health
Reproductive Medicine
Taghride Dahhan
tamoxifen
-
Apr 30, 2026, 18:45AI in Ultrasound Follicular Monitoring Moves Toward Clinical Decision Support – RBMO
-
Apr 30, 2026, 11:42ASRM Encourages Registration for Conference on Practice Growth and Innovation
-
Apr 30, 2026, 11:26ESHRE and ALPHA Launch Global Survey to Update ART Laboratory KPIs
-
Apr 30, 2026, 11:10Susanne Johnson: Advanced Gynaecology Ultrasound Course Day 2
-
Apr 30, 2026, 11:02Platelets Reduce Oxidative Stress Damage in Human Endometrial Stromal Cells in Vitro – RBMO
-
Apr 30, 2026, 10:57GREEG Day 2026: Elevate Your Ultrasound Expertise – GREEG
-
Apr 30, 2026, 10:49Up to Two-Thirds of Elite Female Athletes Experience Irregular Periods – Fertility Plus
-
Apr 30, 2026, 10:47Applications for the ESHRE5 Young Ambassadors 2026 are Still OPEN, But Not for Long! – ESHRE
-
Apr 30, 2026, 10:42The Link Between Lifestyle and Anti-Müllerian Hormone – RBMO